Point State Capital LP Sarepta Therapeutics, Inc. Transaction History

Point State Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $22.9 Million - $32.1 Million	-198,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $14.3 Million - $30.6 Million	198,900 New	198,900 $26.3 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $26.2 Million - $39.9 Million	-485,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $4.02 Million - $4.79 Million	84,400 Added 21.05%	485,400 $27 Million
Q3 2017 Nov 14, 2017	SELL	$35.73 - $47.15 $8.25 Million - $10.9 Million	-230,922 Reduced 36.54%	401,000 $18.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	631,922	631,922 $21.3 Million

528

85M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.